Docoh
Loading...

SNY Sanofi

La vocation de Sanofi est d'accompagner celles et ceux confrontés à des difficultés de santé. Entreprise biopharmaceutique mondiale spécialisée dans la santé humaine qui prévient les maladies avec ses vaccins et propose des traitements innovants. Elle accompagne tant ceux qui sont atteints de maladies rares, que les millions de personnes souffrant d'une maladie chronique. Sanofi et ses plus de 100 000 collaborateurs dans 100 pays transforment l'innovation scientifique en solutions de santé partout dans le monde. Sanofi, Empowering Life, donner toute sa force à la vie.

Company profile

Ticker
SNY, SNYNF
Exchange
Website
CEO
Paul Hudson
Employees
Incorporated
Location
Fiscal year end
Former names
SANOFI SYNTHELABO SA, SANOFI-AVENTIS
SEC CIK
IRS number
133529324

SNY stock data

(
)

Calendar

4 Mar 21
2 Dec 21
31 Dec 21
Quarter (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Sanofi earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
14 Sep 21 Sanofi Common Stock, par value $0.001 per share Buy Acquire P No No 38 20,515,985 779.61M 75,668,031
14 Sep 21 Sanofi Common Stock, par value $0.001 per share Buy Acquire P No No 38 51,467,612 1.96B 55,152,046
2 Aug 21 Sanofi Common Stock (par value, $0.0001) Buy Acquire P Yes No 15 66,667 1M 3,155,169
2 Aug 21 Sanofi Common Stock (par value, $0.0001) Conversion Acquire C Yes No 0 3,088,502 0 3,088,502
2 Aug 21 Sanofi Series B-1 Preferred Stock (par value, $0.0001) Common Stock Conversion Dispose C Yes No 0 354,393 0 0
2 Aug 21 Sanofi Series A-1 Preferred Stock (par value, $0.0001) Common Stock Conversion Dispose C Yes No 0 12,480,498 0 0
28 Jul 20 Sanofi Common Stock (par value $0.0001) Buy Acquire P Yes No 16 81,250 1.3M 520,125
28 Jul 20 Sanofi Common Stock (par value $0.0001) Conversion Acquire C Yes No 0 438,875 0 438,875
28 Jul 20 Sanofi Series A Convertible Preferred Stock (par value, $0.0001) Common Stock Conversion Dispose C Yes No 0 3,279,720 0 0

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

9.3% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 547 554 -1.3%
Opened positions 53 60 -11.7%
Closed positions 60 47 +27.7%
Increased positions 206 218 -5.5%
Reduced positions 165 147 +12.2%
13F shares
Current Prev Q Change
Total value 11.38B 10.64B +7.0%
Total shares 235.77M 201.74M +16.9%
Total puts 374.6K 243.4K +53.9%
Total calls 2.19M 563.6K +289.4%
Total put/call ratio 0.2 0.4 -60.5%
Largest owners
Shares Value Change
Dodge & Cox 94.12M $4.54B +33.9%
Fisher Asset Management 17.91M $863.27M +0.1%
FMR 16.68M $803.96M +0.9%
BLK Blackrock 14.02M $676.14M -3.5%
BAC Bank Of America 10.23M $493.37M +3.1%
TROW T. Rowe Price 5.61M $270.57M +28.0%
IVZ Invesco 5.33M $256.72M -1.9%
Hotchkis & Wiley Capital Management 4.89M $235.89M -4.0%
Boston Partners 4.59M $221.37M NEW
Lazard Asset Management 3.21M $154.53M -1.6%
Largest transactions
Shares Bought/sold Change
Dodge & Cox 94.12M +23.84M +33.9%
Boston Partners 4.59M +4.59M NEW
TROW T. Rowe Price 5.61M +1.23M +28.0%
Point72 Asset Management 2.51M +1.1M +77.9%
Camber Capital Management 3M +750K +33.3%
Healthcare Of Ontario Pension Plan Trust Fund 739.4K +739.4K NEW
Clark Capital Management 628.36K +628.36K NEW
BLK Blackrock 14.02M -513.48K -3.5%
Pictet Asset Management 0 -352.38K EXIT
Millennium Management 521.03K +344.12K +194.5%
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: abovementioned, abrogated, acclimatization, Achondroplasia, adulthood, aggravated, al, Alain, Alameda, Alberta, amcenestrant, Amica, amplify, Ancient, annulment, ANSM, anticancer, antitumor, Antony, Apple, Arnaud, arrondissement, Aspercreme, ATU, aubagio®, Avenue, Azteca, Baltimore, Barbara, Bath, Baxter, BCC, BeiGene, Benelux, BeNeLuxA, Berlin, Bickford, Biden, Bioindustriel, biosecurity, bronchopulmonary, BSL, budgetary, Buu, CAGR, Campath, camrelizumab, capita, Caprelsa, capsule, Carlo, catalyzed, Catholique, causation, CCPA, Centrient, cerebrovascular, Champion, chance, chest, child, chimique, Christel, CINDU, Clinique, Clolar, cluster, CMF, Conceptual, Congenital, Conservation, conspiracy, Copenhagen, COVAX, CRSsNP, CTK, cum, Danish, deception, Decile, desired, developmental, devoted, Diego, disagreed, discriminatory, Disney, Dorflex, downside, downstream, Drewell, DRG, dysfunction, earliest, efanesoctocog, Efanesoctogog, Efluelda, eftrenonacog, eleventh, embed, embrace, EMEA, engender, enjoin, entertainment, entrant, envisaged, EoE, ESG, EUR, EUROAPI, EVF, Evolutive, FD, feeding, fivefold, Fludara, forest, fungal, FWK, galactosidase, GDP, geograophical, globotriaosylceramide, glycogen, glycosphingolipid, gouging, granular, hallmark, harvest, Heath, hedgehog, HEI, hemagglutinin, Hengrui, HepB, HHI, HHS, Holten, HRH, HRSA, ICARIA, IcyHot, IDVR, IFDA, IFP, IgG, imprisonment, impurity, inflection, interference, involuntary, IPTF, ISTH, itepekimab, ITHACA, IVDR, Jiangsu, Julien, Junshi, Jupiter, Karl, Kd, kilogram, Kingfisher, knock, Kymab, Kymera, Lancet, Lauder, Lean, Leber, Legrand, Lisbeth, lockdown, longest, lymphoblastic, Madison, manifest, manslaughter, Marthe, Maryland, MDR, meal, MenQuadfi, Mental, Merlin, MFN, MIT, Monte, Montreal, MSc, multisystemic, muscle, Natalie, nearer, neglected, NEJM, neoadjuvant, NeuroCure, newcomer, NHSA, Nike, nitrosamine, Novalgina, Novanuit, NSQ, nuisance, numerator, OECI, Ongevalle, OnSite, OptumRx, orpermanent, osimertinib, overallotment, Paritech, PDMA, pembrolizumab, PhD, picosulfate, Picower, Pluton, PPH, precipitate, presidential, PRI, Prince, PRN, pushback, quartile, Quebec, Queen, ramucirumab, ravtansine, RDT, reactive, readout, reconnect, recurring, Reddy, rent, restitution, revolving, rHA, rilzabrutinib, Rongheng, Rotkreuz, Rotthier, sanctioned, Sandhoff, Santiago, SBS, Schekman, Scheller, Schnepp, sequence, seventeenth, shape, shaping, Shaw, Sigma, skeletal, skillset, smoldering, spectrum, spleen, stressed, subcontractor, summer, summitted, Supemtek, swallowing, symptom, teamwork, teleconference, tempered, Tesco, Thyrogen, Tianjin, tiered, tislelizumab, tolebrutinib, toripalimab, traction, tranche, Triomphe, Trispecific, TruRapi, Truvelog, TTP, tusamitamab, undisclosed, Unisom, Universiteit, unjustified, Unlisted, upward, uric, van, ventilated, ventilation, Vermont, versa, videoconference, Viking, Vrije, wake, walking, Walt, Warwick, Watch, wP
Removed: acceleration, accessibility, affordability, aggressive, ago, alongside, alphabet, alteration, Alzheimer, Ambien, analyzing, Armenia, arrival, astronaut, Avalide, axa, BA, balancing, Barkat, Basaglar, Bermuda, biopark, Bloomberg, breached, burdensome, Caldecott, caliber, canceled, cancelling, Castaigne, Cayman, Centre, cessation, chairmen, chauffeur, childhood, Cit, coherent, collateralized, College, collegiate, conducive, conference, Congo, Connecticut, controller, CoPlavix, curb, cut, cyclophosphamide, Daiichi, deal, dealing, degradation, difficile, diffuse, diligent, DIS, discouraging, disregard, disrupt, divestiture, DPA, DTaP, dual, Dubai, DuoPlavin, easier, educator, endpoint, enhancing, equaled, Eurasia, familial, feature, fifty, filled, forerunner, foster, FR, Gallen, GCVRZ, Georgia, Google, GPH, grain, greatest, grew, grow, handle, HeFH, Heritage, Hewlett, Hexacima, Hexyon, hypercholesterolemia, IAA, IFPMA, immunized, implicit, inconsistent, indexation, Indian, industrialization, intelligent, intervention, ISDA, Islamic, Karvezide, KDSV, Kitasato, labelled, Lacoste, landscape, Lexicon, liberty, LLP, Lybrand, Lyxumia, Macquarie, Mansuri, match, Meriden, Merrell, methodology, MIR, mix, Morgan, Museum, Muzammil, Myslee, Nanyang, Neucyte, NHI, nineteen, noticeable, NovaQuest, NYSE, occupy, optionally, Oxley, Packard, pathogen, patisiran, percent, Pernod, perspective, Pharmed, Plaza, Polytechnic, predicted, PSU, pursued, recessive, recurrent, rep, resell, reviewing, revision, Ricard, rice, RMS, RNAi, Rubber, Sakigake, Sankyo, SE, Senate, Shekman, Sheller, Singaporean, sotaglifozin, st, Stafford, Stamford, Stargardt, station, Steering, strategically, streamline, systematic, TA, Takeda, TAs, template, terminating, tertiary, Thermalin, threatening, trace, transform, Trump, twelfth, twentieth, Universcience, unknown, unrecognized, unsecured, unsubordinated, uplift, usage, validated, vendor, Verily, Voyager, Western, write

Patents

APP
Utility
Packaging for a Medicament Container
2 Dec 21
The present disclosure relates to a packaging for a medicament container, wherein the medicament container comprises at least one distal container abutment section and at least one proximal container abutment section, the packaging comprising: a bottom and a sidewall structure connected to the bottom, the bottom and the sidewall structure confining a storage space configured to accommodate at least one medicament container, at least one distal packaging abutment section, and at least one proximal packaging abutment section, wherein the at least one distal packaging abutment section is integrated into or arranged at one of the sidewall structure and the bottom and configured to abut with the at least one distal container abutment section, wherein the at least one proximal packaging abutment section is integrated into or arranged at the sidewall structure and configured to abut with the at least one proximal container abutment section.
APP
Utility
Drug Delivery Device
2 Dec 21
The present disclosure relates to an audible and/or tactile indicator for use with a drug delivery device including a resilient force member configured to reside in two or more states having two or more different conformations, wherein in a relaxed state, the resilient force member is relaxed in a first conformation, wherein in a biased state, the resilient force member is biased to store energy in a second conformation different to the first conformation, wherein the resilient force member releases stored energy to generate an audible signal when changing from the biased state into the relaxed state due to a transition from the second conformation to the first conformation, wherein the resilient force member is bent by a certain angle about a longitudinal axis forming a longitudinal round fold with two adjacent angled wing-shaped sections.
APP
Utility
Wireless Electronics Assembly for Injection Devices
2 Dec 21
Electronics assemblies with wireless capabilities for use in a drug delivery device.
APP
Utility
Injection Device with Dose Size Adjuster
2 Dec 21
The present disclosure relates to an injection device configured to expel a dose of a medicament, the injection device comprising: an elongated housing extending in a longitudinal direction, a piston rod movable relative to the housing in a longitudinal distal direction to exert a dispensing pressure onto a bung of a cartridge at least partially filled with an injectable medicament, a rod extension movably arranged on or in a distal end of the piston rod, a driver operably engaged with the piston rod and movable relative to the housing in a longitudinal proximal direction for setting of the dose and movable relative to the housing in the longitudinal distal direction for dispensing of the dose, and an adjuster arranged on or in the driver and operably engaged with the rod extension to move the rod extension in longitudinal direction relative to the piston rod.
APP
Utility
Needle Sheathing Device with Flexible End-Piece for Syringe
2 Dec 21
The invention relates to a safe support device for a syringe, said support comprising a support sheath for the body of a syringe, and safety means which comprise an inner sheath suitable for sliding relative to said support sheath between a waiting retracted position, in which said inner sheath is substantially retracted inside said support sheath, and an active protection position, in which said inner sheath projects from said support sheath.